HOME


BUSINESS APPROACH

  1. PIPELINE ENHANCEMENT

  2. INTELLIGENT PARTNERING SOLUTIONS

  3. FUNDING MODELS


TECHNICAL APPROACH

  1. ZERO TO CANDIDATE

  2. MOLECULAR ANALYSIS OF CLINICAL PROJECTS


PHARMACEUTICAL CONSIDERATIONS

  1. THERAPEUTIC AREA

  2. MOLECULES

  3. DRUG TARGETS


TECHNOLOGIES & CONCEPTS

  1. DRUGGABILITY

  2. OFF TARGET EFFECTS


CASE STUDIES

DISCOVERY SOFTWARE


ABOUT THIS SITE


INTELLIGENT DRUG DISCOVERY SOLUTIONS


We work on behalf of pharmaceutical companies and other institutions to identify and build new opportunities in early stage drug discovery. We call this ‘zero to candidate’.


We also apply the same rigorous approaches to assess the prospects of all third party projects, including those already in the clinic.


Our approaches combine scientific rigour on one hand with the soft business skills also required to identify high quality opportunities for clients


Our capabilities are complementary to both internal pharmaceutical discovery capabilities and the business consultancies who typically focus on the macro-economics of drug discovery.

Read 
more 
here

Telephone +44 1780 762 259

12 High Street, Easton on the Hill,

Near Stamford. PE9 3LR. United Kingdom